Notice No20230321-44Notice Date21 Mar 2023
CategoryCompany relatedSegmentEquity
SubjectClarifications received from the companies
Content

The Exchange has observed significant price/volume movement in following scrips in the recent past. The Exchange in order to ensure that trading member/investors have latest relevant information had written to the following companies. Reply received from them is attached herewith.

1.      Brooks Laboratories Ltd (Security Code: 533543)

2.      Aarti Drugs Ltd (Security Code: 524348)

 

Reply From following companies is awaited:-

1.      Sofcom Systems Ltd (Security Code: 538923)

2.      Caplin Point Laboratories Ltd (Security Code: 524742)

For & On behalf of BSE Ltd

Yogendra Daxini

Saji Sunilkumar

Deputy General Manager

Senior Manager

Surveillance

Surveillance


21st Mar 2023

Attachments
Reply.zip